Abbott Laboratories (ABT) Net Income towards Common Stockholders Growth (3y) (2012 - 2026)
Abbott Laboratories (ABT) Net Income towards Common Stockholders Growth (3y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Income Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.50 Bn | 194.89 Bn | 7.27 Bn | -12.28% |
| 2 | Stryker | 130.00 Bn | 126.52 Bn | 4.50 Bn | 20.02% |
| 3 | Medtronic | 120.36 Bn | 111.14 Bn | 6.41 Bn | 1.93% |
| 4 | Boston Scientific | 74.19 Bn | 73.65 Bn | 3.85 Bn | 51.47% |
| 5 | Edwards Lifesciences | 52.73 Bn | 48.48 Bn | 1.35 Bn | -7.83% |
| 6 | Dexcom | 34.64 Bn | 32.70 Bn | 830.00 Mn | 29.05% |
| 7 | GE HealthCare Technologies | 34.13 Bn | 32.02 Bn | 2.18 Bn | 11.15% |
| 8 | Koninklijke Philips | 26.52 Bn | 23.20 Bn | 4.55 Bn | 1,825.47% |
| 9 | Steris | 23.23 Bn | 22.75 Bn | 684.20 Mn | 17.54% |
| 10 | Zimmer Biomet Holdings | 19.39 Bn | 18.98 Bn | 1.54 Bn | -1.66% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -12.28% |
| Mar 31, 2026 | -6.51% |
| Dec 31, 2025 | 19.80% |
| Sep 30, 2025 | 4.64% |
| Jun 30, 2025 | -4.11% |
| Mar 31, 2025 | -18.39% |
| Dec 31, 2024 | 67.02% |
| Sep 30, 2024 | -7.68% |
| Jun 30, 2024 | 3.22% |
| Mar 31, 2024 | -11.79% |
| Dec 31, 2023 | -9.51% |
| Sep 30, 2023 | 5.41% |
| Jun 30, 2023 | 37.06% |
| Mar 31, 2023 | 32.94% |
| Dec 31, 2022 | -0.35% |
| Sep 30, 2022 | 14.58% |
| Jun 30, 2022 | 26.37% |
| Mar 31, 2022 | 53.96% |
| Dec 31, 2021 | 45.06% |
| Sep 30, 2021 | 55.16% |